ES2179671T3 - Rapamicinas fotociclizadas. - Google Patents

Rapamicinas fotociclizadas.

Info

Publication number
ES2179671T3
ES2179671T3 ES99941166T ES99941166T ES2179671T3 ES 2179671 T3 ES2179671 T3 ES 2179671T3 ES 99941166 T ES99941166 T ES 99941166T ES 99941166 T ES99941166 T ES 99941166T ES 2179671 T3 ES2179671 T3 ES 2179671T3
Authority
ES
Spain
Prior art keywords
rapamicines
photociclized
antiproliferative
antiinflammatory
immunosuppressive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES99941166T
Other languages
English (en)
Inventor
Tianmin Zhu
Hyuk-Koo Lee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
Wyeth LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth LLC filed Critical Wyeth LLC
Application granted granted Critical
Publication of ES2179671T3 publication Critical patent/ES2179671T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Transplantation (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Rapamicinas fotociclizadas. Esta invención se refiere a rapamicinas fotociclizadas y a un método para utilizarlas en la inducción de la inmunosupresión y en el tratamiento del rechazo de trasplantes, enfermedad del injerto contra el huésped, enfermedades autoinmunitarias, enfermedades inflamatorias, leucemia/linfoma de células T adultas, tumores sólidos, micosis y trastornos vasculares hiperproliferativos. La rapamicina es un antibiótico triénico macrocíclico producido por Streptomyces hygroscopicus, del que se encontró que tenía actividad antifúngica, especialmente contra Candida albicans, tanto in vitro como in vivo. La rapamicina sola o en combinación con picibanil ha demostrado tener actividad antitumoral. R. Martel y cols. describieron cómo la rapamicina es eficaz en el modelo de encefalomielitis alérgica experimental, un modelo de esclerosis múltiple; en el modelo de artritis con adyuvantes, un modelo de artritis reumatoide; e inhibe de forma eficaz la formación de anticuerpos de tipoIgE.
ES99941166T 1998-08-17 1999-08-16 Rapamicinas fotociclizadas. Expired - Lifetime ES2179671T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13542198A 1998-08-17 1998-08-17

Publications (1)

Publication Number Publication Date
ES2179671T3 true ES2179671T3 (es) 2003-01-16

Family

ID=22468034

Family Applications (1)

Application Number Title Priority Date Filing Date
ES99941166T Expired - Lifetime ES2179671T3 (es) 1998-08-17 1999-08-16 Rapamicinas fotociclizadas.

Country Status (12)

Country Link
EP (1) EP1105395B1 (es)
JP (1) JP2002522543A (es)
CN (1) CN1323310A (es)
AT (1) ATE219492T1 (es)
AU (1) AU5487499A (es)
BR (1) BR9913052A (es)
CA (1) CA2340700A1 (es)
DE (1) DE69901907T2 (es)
DK (1) DK1105395T3 (es)
ES (1) ES2179671T3 (es)
PT (1) PT1105395E (es)
WO (1) WO2000009510A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1768662A2 (en) 2004-06-24 2007-04-04 Novartis Vaccines and Diagnostics, Inc. Small molecule immunopotentiators and assays for their detection
ES2380779T3 (es) 2004-12-20 2012-05-18 Wyeth Llc Análogos de rapamicina y usos de los mismos en el tratamiento de trastornos neurológicos, proliferativos e inflamatorios
MX2007007409A (es) 2004-12-20 2007-07-12 Wyeth Corp Derivados de rapamicina y los usos de los mismos en el tratamiento de trastornos neurologicos.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9221220D0 (en) * 1992-10-09 1992-11-25 Sandoz Ag Organic componds

Also Published As

Publication number Publication date
DK1105395T3 (da) 2002-10-14
PT1105395E (pt) 2002-09-30
CA2340700A1 (en) 2000-02-24
CN1323310A (zh) 2001-11-21
DE69901907D1 (de) 2002-07-25
EP1105395A1 (en) 2001-06-13
WO2000009510A1 (en) 2000-02-24
JP2002522543A (ja) 2002-07-23
AU5487499A (en) 2000-03-06
ATE219492T1 (de) 2002-07-15
DE69901907T2 (de) 2002-12-19
BR9913052A (pt) 2001-05-08
EP1105395B1 (en) 2002-06-19

Similar Documents

Publication Publication Date Title
EP0781776A3 (en) Water soluble rapamycin esters
ES2158959T3 (es) N-oxido esteres de la rapamicina impedidos y su utilizacion como medicamentos.
DE69428282D1 (de) Dünnwandiges, fugenloses, poröses polytetrafluoroäthylenrohr
ITRM960325A0 (it) Radiotelefono con cerniera incorporata.
DK0589703T3 (da) Prolinderivater af rapamycin, fremstilling og anvendelse deraf
DK1040108T3 (da) Orthoanthranilamidderivater som antikoagulanter
DE59104962D1 (de) Als Richtmikrophon ausgebildeter Telephonhandapparat.
ES2179671T3 (es) Rapamicinas fotociclizadas.
EA199800089A1 (ru) Газопроницаемый материал
EA199800506A1 (ru) Микрокоммиссуротом с рычагами
DE69702441T2 (de) Pyridinderivate als fungizide
DE60136430D1 (de) Heterosubstituierte c7-taxanacetate als antitumormittel
MY132596A (en) Hydride gas detecting tape
DE60138853D1 (de) C10-taxanester als antitumormittel
DK1032580T3 (da) Fremgangsmåde til N-desmethylering af erythromyciner og derivater deraf
NL1011975A1 (nl) Elektronenkanon.
ES2175228T3 (es) Metilsulfomicina i, un procedimiento para su produccion y su uso.
FI982327A0 (fi) Sovitelma puhelimen handsfree-toiminnoksi
ES2152825A1 (es) Metodo general de obtencion de esteres del acido poli (-glutamico) mediante transesterificacion.
FI982567A (fi) Sovitelma puhelimen handsfree-toiminnoksi
ES1032766Y (es) Estructura mejorada de ventana de carpinteria metalica.
KR970003474U (ko) 자동이득제어회로를 적용한 무선 데이터/음성 수신장치
NO965532L (no) Induktivt byggeelement for demping av stöy i takt og i mottakt
DK1100821T3 (da) Antiinflammatoriske forbindelser afledt af lipocortin-1
DE29812749U1 (de) Fahrbare, kompakte Kleinwerkbank